Drug Approval | December 17, 2023
Zydus receives final USFDA approval for Cyclophosphamide Capsules USP, 25 mg and 50 mg
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
The company will submit its comprehensive response on these observations to the USFDA
Subscribe To Our Newsletter & Stay Updated
